Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$6.21 +0.01 (+0.16%)
As of 07/4/2025 04:00 PM Eastern

ACB vs. THCX, CRON, GUD, TLRY, WEED, FIRE, EPI, OGI, CPH, and ICC

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), Cipher Pharmaceuticals (CPH), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
Hydropothecary N/A N/A N/A

In the previous week, Aurora Cannabis had 1 more articles in the media than Hydropothecary. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Hydropothecary. Aurora Cannabis' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Aurora Cannabis Neutral
Hydropothecary Neutral

Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$195.83M1.73-C$44.16M-C$0.81-7.67
HydropothecaryN/AN/AN/AN/AN/A

13.4% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aurora Cannabis currently has a consensus price target of C$8.75, suggesting a potential upside of 40.90%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities research analysts plainly believe Aurora Cannabis is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Aurora Cannabis beats Hydropothecary on 6 of the 9 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$339.74MC$2.13BC$5.56BC$6.19B
Dividend YieldN/A2.92%5.24%6.72%
P/E Ratio-7.674.1827.6450.85
Price / Sales1.73566.59416.551,194.54
Price / Cash1.2510.3536.8983.29
Price / Book0.5611.628.034.69
Net Income-C$44.16MC$21.15BC$3.18BC$301.20M
7 Day Performance8.76%1.82%2.93%2.29%
1 Month Performance-20.49%6.41%1.72%4.22%
1 Year Performance-5.48%2.54%34.39%26.95%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.718 of 5 stars
C$6.21
+0.2%
C$8.75
+40.9%
-5.5%C$339.74MC$195.83M-7.671,073
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.61
+0.4%
N/A-9.2%C$689.21MC$76.86M-14.52450
GUD
Knight Therapeutics
N/AC$5.83
+1.4%
C$7.15
+22.6%
+6.3%C$589.71MC$348.70M-19.46725
TLRY
Tilray Brands
N/AC$0.56
+3.7%
N/A-71.4%C$360.85MC$610.34M-1.352,650News Coverage
WEED
Canopy Growth
0.7195 of 5 stars
C$1.68
-0.6%
C$2.20
+31.0%
-79.6%C$270.26MC$519.68M-0.252,700News Coverage
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
OGI
Organigram
3.2406 of 5 stars
C$1.84
flat
C$3.33
+80.7%
-12.0%C$227.32MC$180.58M-3.89987News Coverage
CPH
Cipher Pharmaceuticals
N/AC$12.54
-1.8%
C$14.75
+17.6%
+61.7%C$225.13MC$19.03M13.855
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up

Related Companies and Tools


This page (TSE:ACB) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners